IVF 2021 OPTIMISTIC FUTURE? MUDr. tpn Macha, Ph.D. IVF Clinic, - - PowerPoint PPT Presentation

ivf 2021 optimistic future
SMART_READER_LITE
LIVE PREVIEW

IVF 2021 OPTIMISTIC FUTURE? MUDr. tpn Macha, Ph.D. IVF Clinic, - - PowerPoint PPT Presentation

IVF 2021 OPTIMISTIC FUTURE? MUDr. tpn Macha, Ph.D. IVF Clinic, Olomouc IVF 2018 Around 2,4 million ART cycles are estimated each year, with about 500 000 babies born. 2-6% live births in Europe by ART. World data analysis


slide-1
SLIDE 1

IVF 2021 – OPTIMISTIC FUTURE?

  • MUDr. Štěpán Machač, Ph.D.

IVF Clinic, Olomouc

slide-2
SLIDE 2

IVF 2018

  • Around 2,4 million ART cycles are estimated each year, with about

500 000 babies born.

  • 2-6% live births in Europe by ART.
  • World data analysis 2013.
  • Delivery rate per aspiration 19,2%.
  • Cumulative delivery rate per single started cycle 27,4%.

Human Fatemi, 8th IVIARM Congress, Palma, 2019

slide-3
SLIDE 3

VISION IN IVF - TARGETS

  • Achieve the highest success rate (take home baby rate).
  • Successfully treat all reproductive medicine diagnosis.
  • Use up-to-date procedures and technics.
  • Introduce new evidence based methods.
  • Safety women + reduce burden of ART.
  • Child health.
  • Cost.
  • Access to care.
slide-4
SLIDE 4

ART TREATMENT – OVARIAN STIMULATION

  • Minimize Complications and Risks.
  • Cycle Cancellation (poor responder).
  • Avoid multiple pregnancy.
  • OHSS.
  • Maximize Beneficial Effects.
  • Singleton live birth at term.
slide-5
SLIDE 5

VISIONAIRES IN IVF

Norbert Gleicher Bart Fauser Juan Garcia Velasco

slide-6
SLIDE 6

VISIONARY IN IVF

Norbert Gleicher Center Human Reproduction, New York, N.Y., USA; Foundation for Reproductive Medicine, New York, USA; Stem Cell Biology and Molecular Embryology Laboratory, The Rockefeller University, New York, N.Y., USA;

  • Reproductive immunology.
  • DHEA.
  • FET of aneuploid embryos after PGT-A
  • Stimulation of low responder a poor prognosis

patients.

slide-7
SLIDE 7

VISIONARY IN IVF

Worldwide declines of in vitro fertilization (IVF) birth rates and their probable causes – unpublished.

15% 20% 25% 30% 35% 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014

Live Birth per Fresh ART Cycle (%)

U.S. annual live birth rates following autologous IVF cycles 1995 to 2014

slide-8
SLIDE 8

VISIONARY IN IVF

  • Database (ANZARD)

https://npesu.unsw.edu.au/, accessed December 25, 2018.

  • Canada Fertility & Andrology

Society Annual Reports (CARTR) https://cfas.ca/cartr-annual- reports/, accessed November 20, 2018-

  • Japan Society of Assisted

Reproduction.

  • Latin American Network of Assisted

Reproduction( www.redlara.com, accessed November 20, 2018).

  • Hum (www.hfea.gov.uk/fertility-

clinics-success-rates.html), accessed November 20, 2018 and CDC for United States.

slide-9
SLIDE 9

ELECTIVE SINGLE ET

0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014

% SET in Fresh ART Cycles

Australia and New Zealand Canada Japan Latin America UK US

slide-10
SLIDE 10

VISIONARY IN IVF

0% 2% 4% 6% 8% 10% 12% 14% 16% 50000 100000 150000 200000 250000 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013

Live Birth per Fresh ART cycle (%) Total Fresh Autolgous Cycles

Japan

Cycles Live Birth Rate

slide-11
SLIDE 11

VISIONARY IN IVF

0% 5% 10% 15% 20% 25% 5000 10000 15000 20000 25000 30000 35000 40000 45000 50000 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014

Live Birth per Fresh ART cycle (%) Total Fresh Autolgous Cycles

Australia and New Zealand

Cycles Live Birth Rate

slide-12
SLIDE 12

VISIONARY IN IVF

Table 1. Newly introduced additions that may have adversely affected IVF outcomes Embryo selection Extended embryo culture to blastocyst Elective single embryo transfer (eSET) Closed embryo incubation systems with time lapse imaging Preimplantation genetic screening (PGS)* Mild ovarian stimulations “Mini-IVF” Natural cycle IVF Patient-friendly IVF Cycle interruptions All freeze cycles with frozen-thawed cycle to follow Embryo banking with combined frozen-thawed cycle to follow

slide-13
SLIDE 13

VISIONARY IN IVF

Bart Fauser University Medical Center Utrecht, Department of Reproductive Medicine

  • International consensus on the definition of PCOS.
  • Worldwide trend towards milder and safer IVF.
  • Editor in Chief Reproductive Biomedicine Online.
  • Former Chair od WHO steering committee for

infertility guidelines.

slide-14
SLIDE 14

BASIC QUESTIONS

  • Do we know what to report?
  • Standard success rate in IVF.
  • What procedures and techniques help to

achieve our vision?

slide-15
SLIDE 15

WHAT TO REPORT?

2004

slide-16
SLIDE 16

VISIONARY IN IVF

slide-17
SLIDE 17

VISIONARY IN IVF

slide-18
SLIDE 18

VISIONARY IN IVF

slide-19
SLIDE 19

VISIONARY IN IVF

Juan Antonio Garcia Velasco IVIRMA , Director of IVF Madrid

  • Co-Editor of Reproductive Biomedicine Online.
  • Endometriosis and hypo- and hyper-ovarian.

stimulation response

  • Reproductive immunology.
  • Onco-fertility preservation.
  • Personalized IVF stimulation.
slide-20
SLIDE 20

ART 2021

  • Big data will help individualize much more

the treatments.

  • Much better embryos selection – SET all.
  • More simple treatment.
  • Better results due to better. understanding
  • f areas that we do not understand now.

OPTIMISTIC

slide-21
SLIDE 21

TAYLORED ART - INDIVIDUALIZED

37%

Hershkop et al, RBMO, 2017

slide-22
SLIDE 22

PATIENTS CENTRED MEDICINE

  • Looks back to the individual patient.
  • Best health care to each of them.
  • Based on careful individual
  • bservation.
  • Takes into account patients:
  • Preferences
  • Economical resources
slide-23
SLIDE 23

AUTHORITIES AND MASS MEDIA

slide-24
SLIDE 24

AUTHORITY STRATEGY

Strategy 2017-20

Treatment add ons 3.3. One area of work that we have already started is treatment ‘add ons’ which have become a feature of many IVF services. Increasingly, patients are being offered a variety of treatments – including drug regimes, methods for culturing embryos and treatment procedures – with the claim that they improve the chances of a successful pregnancy. Some patient feedback indicates that many now see such treatments as an indicator of a good service. Yet the evidence base for many of these treatments is weak. Our new website will give information about these add ons and we are discussing collaborative work with the professional bodies and patient groups. How might we want to progress this work further in 2017-20? Treatment costs 3.4. We are not an economic regulatora, nd have no direct levers to pull around the cost of treatment, but this is one of patients’ top concerns. Although our new website won’t list prices for each clinic, it will give patients information about the range of costs across UK clinics. It will also give patients a chance to give feedback on the patient ratings feature about whether they paid what the clinic estimated treatment would cost.

slide-25
SLIDE 25

AUTHORITY STRATEGY

Harper J. et al., HumReprod, 2017

slide-26
SLIDE 26

MASS MEDIA

slide-27
SLIDE 27

OHSS REPORTED

Daily Mail, Fertility Clinics accused of covering up potentially fatal side effects of IVF

slide-28
SLIDE 28

GOOD PHYSICIAN TREATS THE DISEASE

GREAT PHYSICIAN TREATS THE PATIENT WHO HAS THE DISEASE